A scientist at the Centre for Cancer Immunology has been involved in a study that shows, for the first time, the real-world vaccine responses and infection outcomes in clinically at-risk patients with a range of immunocompromised or immunosuppressed conditions.
Copy and paste this URL into your WordPress site to embed
